# VERTEX PHARMACEUTICA (VRTX) — Q3-2011 Earnings Results

**Report date:** 2011-10-27 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/VRTX/earnings/Q3-2011

## Post-Earnings Brief

### Headline

Vertex Pharmaceuticals Beats on EPS, Stock Down 0.72%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.70 | N/A | +248.26% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record for this earnings call, so the analysis is based solely on the numerical results.

### Guidance Changes

No forward guidance data is available for this quarter.

### What It Means

Vertex Pharmaceuticals reported a strong earnings surprise with an EPS of $0.70, significantly exceeding expectations. However, the stock reacted negatively, declining by 0.72%. This suggests that despite the positive earnings, investors may have concerns about other aspects of the company's performance or future outlook.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/VRTX/earnings/Q3-2011_